Stock Earnings

Question 1

Dermapharm Holding SEの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Dermapharm Holding SEの総資産は$2,080で、純profitは$113です。

Question 2

DMPHFの主要な財務比率は何ですか？

Accepted Answer

Dermapharm Holding SEの流動比率は1.41、純利益率は9.57、1株当たり売上高は$21.91です。

Question 3

Dermapharm Holding SEの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Dermapharm Holding SE largest revenue segment is Branded Medicine, at a revenue of 585,058,000 in the most earnings release.For geography, Germany is the primary market for Dermapharm Holding SE, at a revenue of 725,563,000.

Question 4

Dermapharm Holding SEは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、Dermapharm Holding SEの純profitは$113です。

Question 5

Dermapharm Holding SEに負債はありますか？

Accepted Answer

yes、Dermapharm Holding SEの負債は1,475です。

Question 6

Dermapharm Holding SEの発行済株式数は何株ですか？

Accepted Answer

Dermapharm Holding SEの総発行済株式数は53.84株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,176	1,180	1,135	1,024	942	793
Revenue Growth (YoY)	4%	4%	11%	9%	19%	13%
Cost of Revenue	403	413	416	363	322	330
Gross Profit	772	767	719	660	620	463
Selling, General & Admin	287	424	418	290	257	257
Research & Development	--	11	10	13	14	12
Operating Expenses	554	539	518	377	325	320
Other Non Operating Income (Expenses)	0	-4	-3	-1	0	-1
Pretax Income	163	172	105	216	292	125
Income Tax Expense	57	60	45	83	84	39
Net Income	107	113	62	134	209	85
Net Income Growth	28.99%	82%	-54%	-36%	146%	10%
Shares Outstanding (Diluted)	53.57	53.84	53.84	53.84	53.84	53.84
Shares Change (YoY)	0%	0%	0%	0%	0%	0%
EPS (Diluted)	1.99	2.11	1.15	2.49	3.89	1.59
EPS Growth	28.99%	82%	-54%	-36%	144%	11%
Free Cash Flow	175	163	177	249	189	91
Free Cash Flow Per Share	3.26	3.02	3.28	4.62	3.51	1.69
Gross Margin	65.64%	65%	63.34%	64.45%	65.81%	58.38%
Operating Margin	18.53%	19.23%	17.62%	27.63%	31.31%	17.9%
Profit Margin	9.09%	9.57%	5.46%	13.08%	22.18%	10.71%
Free Cash Flow Margin	14.88%	13.81%	15.59%	24.31%	20.06%	11.47%
EBITDA	302	313	301	377	340	185
EBITDA Margin	25.68%	26.52%	26.51%	36.81%	36.09%	23.32%
D&A For EBITDA	84	86	101	94	45	43
EBIT	218	227	200	283	295	142
EBIT Margin	18.53%	19.23%	17.62%	27.63%	31.31%	17.9%
Effective Tax Rate	34.96%	34.88%	42.85%	38.42%	28.76%	31.2%

Dermapharm Holding SE (DMPHF) Price

DMPHF Stock Price Chart

DMPHF Income

Follow-Up Questions